Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shuttleworth

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Thrombosis Research|May 15, 1982
A pilot study of the effect of Gemfibrozil on some haematological parametersJ R O'Brien, M D Etherington, R D Shuttleworth, et al.
Infection and Immunity|December 1, 1991
Epitope mapping of the alpha-toxin of Clostridium perfringensA J Logan, E D Williamson, R W Titball, et al.
Infection and Immunity|February 1, 1989
Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringensR W Titball, S E Hunter, K L Martin, et al.
Scientific Reports|February 4, 2018
Early Detection of Apathetic Phenotypes in Huntington's Disease Knock-in Mice Using Open Source ToolsShawn Minnig, Robert M Bragg, Hardeep S Tiwana, et al.
Plos One|April 29, 2017
Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's diseaseSydney R Coffey, Robert M Bragg, Shawn Minnig, et al.
Scientific Reports|March 29, 2017
Corrigendum: Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt<sup>Q111/+</sup> model of Huntington's diseaseRobert M Bragg, Sydney R Coffey, Rory M Weston, et al.
Scientific Reports|February 9, 2017
Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt<sup>Q111/+</sup> model of Huntington's diseaseRobert M Bragg, Sydney R Coffey, Rory M Weston, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Thrombosis Research|May 15, 1982
A pilot study of the effect of Gemfibrozil on some haematological parametersJ R O'Brien, M D Etherington, R D Shuttleworth, et al.
Infection and Immunity|December 1, 1991
Epitope mapping of the alpha-toxin of Clostridium perfringensA J Logan, E D Williamson, R W Titball, et al.
Infection and Immunity|February 1, 1989
Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringensR W Titball, S E Hunter, K L Martin, et al.
Scientific Reports|February 4, 2018
Early Detection of Apathetic Phenotypes in Huntington's Disease Knock-in Mice Using Open Source ToolsShawn Minnig, Robert M Bragg, Hardeep S Tiwana, et al.
Plos One|April 29, 2017
Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's diseaseSydney R Coffey, Robert M Bragg, Shawn Minnig, et al.
Scientific Reports|March 29, 2017
Corrigendum: Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt<sup>Q111/+</sup> model of Huntington's diseaseRobert M Bragg, Sydney R Coffey, Rory M Weston, et al.
Scientific Reports|February 9, 2017
Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt<sup>Q111/+</sup> model of Huntington's diseaseRobert M Bragg, Sydney R Coffey, Rory M Weston, et al.
Pageof 6